Streetbeat News

Products Services

PLUG

Plug Power Inc. (NASDAQ:PLUG) shares dropped over 5% in premarket trading on Wednesday after a 31% surge the previous day. The decline follows Truist Securities analyst Jordan Levy reiterating a Hold rating and halving the price target from $6 to $3, citing long-term visibility concerns and reducing FY25E revenues. Despite Plug Power announcing the start of operations at the largest U.S. liquid green hydrogen plant, the company faces challenges, including a significant year-over-year share price drop and supply issues in its hydrogen network.

Portfolio Pulse from Nabaparna Bhattacharya

January 24, 2024 | 1:19 pm

MRDB

MariaDB plc (NYSE:MRDB) has completed the spinoff of its geospatial business to CubeWerx, an independent company specializing in geospatial products and services. This move allows MariaDB to concentrate on its core product, the MariaDB Enterprise Server, while CubeWerx takes over the geospatial solution.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:18 pm

URGN

UroGen Pharma Ltd. has initiated the submission of a rolling New Drug Application (NDA) to the FDA for UGN-102, a treatment for low-grade, intermediate-risk non-muscle invasive bladder cancer. The company submitted the Chemistry, Manufacturing, and Controls (CMC) section and plans to complete the NDA in 2024, with a potential FDA decision by early 2025. UGN-102 utilizes UroGen's RTGel technology for sustained release and is currently in Phase 3 development.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:18 pm

STVN

Stevanato Group S.p.A. (NYSE:STVN) has launched the EZ-fill Kit and a non-GMP laboratory fill and finish service to support small batch drug development and commercialization. The EZ-fill Kit, part of Stevanato's ready-to-use platform, offers customizable solutions for injectables, which make up over 60% of drugs in development. The kit will be available in Q2 2024 and will be showcased at Pharmapack. The non-GMP service at the Technology Excellence Centers in the USA and Italy helps customers assess fill-and-finish process effects early on. These offerings aim to improve drug manufacturing standards and speed up market entry for new biopharmaceuticals.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:17 pm

TFFP

TFF Pharmaceuticals is set to present data from its Phase 2 trial of Voriconazole Inhalation Powder, aimed at treating Invasive Pulmonary Aspergillosis, at the 11th Advances Against Aspergillosis & Mucormycosis Conference.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:17 pm

FCX

Freeport-McMoRan Inc. has projected its consolidated sales for 2024 to be around 4.1 billion pounds of copper, 2 million ounces of gold, and 85 million pounds of molybdenum. The first quarter of 2024 is expected to contribute 1 billion pounds of copper, 575 thousand ounces of gold, and 20 million pounds of molybdenum to these totals.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:14 pm

PRSO

Peraso Inc. (NASDAQ:PRSO) has received its first commercial order for the Perspectus mmWave antenna modules, designed to support the DUNE platform in dense urban environments. The order validates Peraso's concept and its ability to deliver affordable gigabit wireless to underserved markets. The PRM2144X module, with its 128 element phased array antenna, is tailored for dense urban areas and also benefits suburban and rural deployments. Peraso's technology aims to address broadband infrastructure challenges and expand internet access in congested networks using its license-free 60 GHz network solutions.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:13 pm

PSQH

PSQ Holdings, Inc. (NYSE:PSQH), operating as PublicSquare, has announced a partnership with Credova, a Buy Now Pay Later (BNPL) solutions provider. This collaboration integrates Credova's technology into PublicSquare's marketplace, granting access to Credova's 2.8 million customers and 4,000 vendors. The partnership aims to create an 'uncancellable' payment ecosystem, particularly benefiting the firearms and outdoor recreation industries. It is set to launch in Q2 2024 and is expected to enhance sales and financing opportunities while securing transactions against cancellations, supporting Second Amendment rights.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:10 pm

TWST

Twist Bioscience Corporation (NASDAQ:TWST) has expanded its Twist Express Genes service to include larger DNA preparations up to 1 milligram. The service, which offers a turnaround starting at five business days, now covers midiprep and maxiprep DNA preparations. This expansion enables researchers in various fields to access rapid gene synthesis at all scales, facilitating large scale experimentation and accelerating research and discoveries. Twist leverages its silicon-based DNA synthesis platform and the expanded layout of its Wilsonville facility to deliver these services with dynamic pricing.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:10 pm

FCX

Freeport-McMoRan reported Q4 average realized prices of $3.81/lb for copper, $2,034/oz for gold, and $20.66/lb for molybdenum. Annual prices for 2023 were $3.85/lb for copper, $1,972/oz for gold, and $24.64/lb for molybdenum.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:08 pm